Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.45 USD | +0.76% | -2.78% | -3.99% |
03:44pm | J&J: studies the potential of nipocalamib in anemia | CF |
12:56pm | J&J: promising data for Tecvayli in myeloma | CF |
Chart calendar Johnson & Johnson
Upcoming events on Johnson & Johnson
Past events on Johnson & Johnson
2024-11-25 | Détachement de |
2024-11-18 02:00 pm | American College of Rheumatology Meeting - scRNAseq SjD Predictors |
2024-11-18 10:55 am | Stifel Healthcare Conference |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2047 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2357 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2353 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:1904 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2316 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2342 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:1912 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2001 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2416 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:1976 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:1988 |
2024-11-18 10:30 am | American College of Rheumatology Meeting - Poster No:2294 |
2024-11-18 09:00 am | American College of Rheumatology Meeting - Poster No:2527 |
2024-11-17 03:00 pm | American College of Rheumatology Meeting - BRASS 3 RA Remission |
2024-11-17 10:30 am | American College of Rheumatology Meeting - Poster No:1496 |
2024-11-17 10:30 am | American College of Rheumatology Meeting - Poster No:1132 |
2024-11-17 10:30 am | American College of Rheumatology Meeting - Poster No:1474 |
Past dividends on Johnson & Johnson
2024-11-25 | Quarterly 1.24 USD |
2024-08-26 | Quarterly 1.24 USD |
2024-05-19 | Quarterly 1.24 USD |
2024-02-15 | Quarterly 1.19 USD |
2023-11-19 | Quarterly 1.19 USD |
2023-08-24 | Quarterly 1.19 USD |
2023-05-21 | Quarterly 1.19 USD |
2023-02-16 | Quarterly 1.13 USD |
2022-11-20 | Quarterly 1.13 USD |
2022-08-21 | Quarterly 1.13 USD |
2022-05-22 | Quarterly 1.13 USD |
2022-02-17 | Quarterly 1.06 USD |
2021-11-21 | Quarterly 1.06 USD |
2021-08-22 | Quarterly 1.06 USD |
2021-05-23 | Quarterly 1.06 USD |
2021-02-21 | Quarterly 1.01 USD |
2020-11-22 | Quarterly 1.01 USD |
2020-08-23 | Quarterly 1.01 USD |
2020-05-21 | Quarterly 1.01 USD |
2020-02-23 | Quarterly 0.95 USD |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 93 775 94 304 -0.56% | 94 943 95 017 -0.08% | 85 159 84 764 0.47% | 88 784 | 91 329 | 94 695 |
EBITDA Million USD | Released Forecast Spread | 36 634 33 066 10.79% | 32 630 32 564 0.2% | 30 414 31 998 -4.95% | 30 468 | 32 898 | 35 170 |
EBIT Million USD | Released Forecast Spread | 29 244 30 088 -2.8% | 29 965 29 608 1.21% | 27 460 27 881 -1.51% | 26 974 | 29 447 | 31 128 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 22 776 24 759 -8.01% | 21 725 25 756 -15.65% | 15 062 20 454 -26.36% | 22 891 | 24 304 | 25 790 |
Net income Million USD | Released Forecast Spread | 20 878 22 542 -7.38% | 17 941 20 668 -13.19% | 35 153 19 696 78.48% | 17 499 | 20 759 | 22 291 |
EPS USD | Released Forecast Spread | 7,81 8,42 -7.29% | 6,73 7,95 -15.29% | 13,7 8,44 62.56% | 6,86 | 8,74 | 9,41 |
Announcement Date | 25/01/22 | 24/01/23 | 23/01/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 24 746 23 599 4.86% | 25 530 24 668 3.49% | 21 351 21 049 1.43% | 21 395 21 017 1.8% | 21 383 21 386 -0.01% | 22 447 22 337 0.49% | 22 471 22 171 1.35% | 22 450 | 22 042 | 22 933 | 23 193 | 23 238 | 23 269 | 24 312 | 24 541 |
EBITDA Million USD | Released Forecast Spread | 8 880 8 484 4.66% | 8 912 8 671 2.78% | 8 071 7 683 5.04% | 6 333 6 788 -6.7% | 7 973 7 747 2.92% | 8 388 8 129 3.18% | 7 164 7 063 1.43% | 6 250 | 8 425 | 8 420 | 8 273 | 7 799 | 8 689 | 9 118 | 7 902 |
EBIT Million USD | Released Forecast Spread | 8 204 7 411 10.7% | 8 189 7 753 5.62% | 7 374 6 967 5.83% | 5 638 6 015 -6.27% | 7 236 7 203 0.46% | 7 712 7 433 3.76% | 6 489 6 085 6.63% | 5 469 | 7 393 | 7 567 | 7 501 | 6 845 | 7 835 | 8 263 | 7 045 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -737 6 708 -110.99% | 6 762 7 242 -6.63% | 5 217 7 202 -27.56% | 4 826 5 043 -4.3% | 6 440 6 329 1.75% | 5 748 6 910 -16.82% | 3 338 4 923 -32.2% | 4 971 | |||||||
Net income Million USD | Released Forecast Spread | -68,0 5 573 -101.22% | 5 144 5 866 -12.3% | 26 028 | 4 049 3 880 4.34% | 5 354 5 293 1.15% | 4 686 5 093 -8% | 2 694 4 083 -34.02% | 4 287 | 6 529 | 6 797 | 5 727 | 6 195 | 6 754 | 7 114 | 6 119 |
EPS USD | Released Forecast Spread | -0,03 2,10 -101.43% | 1,96 1,89 3.45% | 10,2 2,17 370.51% | 1,67 1,68 -0.81% | 2,20 2,21 -0.57% | 1,93 2,09 -7.72% | 1,11 1,69 -34.13% | 1,70 | 2,47 | 2,56 | 2,35 | 2,38 | 2,83 | 2,98 | 2,56 |
Announcement Date | 18/04/23 | 20/07/23 | 17/10/23 | 23/01/24 | 16/04/24 | 17/07/24 | 15/10/24 | - | - | - | - | - | - | - | - |
Past sector events for Johnson & Johnson
Today 07:01 pm | BORA PHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
2024-12-04 02:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: November 2024 Sales and Revenue Release |
2024-11-28 | DOTTIKON ES HOLDING AG: Q2 2025 Earnings Release |
2024-11-15 01:38 am | BAVARIAN NORDIC A/S: Q3 2024 Earnings Release |
2024-11-14 11:01 pm | CSPC PHARMACEUTICAL GROUP LTD.: Q3 2024 Earnings Release |
2024-11-14 09:03 am | GUFIC BIOSCIENCES LIMITED: Q2 2025 Earnings Release |
2024-11-14 07:00 am | OCULAR THERAPEUTIX, INC.: Q3 2024 Earnings Release |
2024-11-14 02:49 am | IPCA LABORATORIES LIMITED: Q2 2025 Earnings Release |
2024-11-14 01:30 am | DERMAPHARM HOLDING SE: Q3 2024 Earnings Release |
2024-11-14 01:30 am | ALK-ABELLÓ A/S: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
- Calendar Johnson & Johnson